Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics

OBJECTIVE: Recurrent hyperkalemia frequently limits use of renin–angiotensin–aldosterone system inhibitors (RAASi) in chronic kidney disease (CKD) patients with hypertension, diabetes, and/or heart failure. Patiromer is a sodium-free, nonabsorbed potassium (K(+))-binding polymer approved by the US F...

Descripción completa

Detalles Bibliográficos
Autores principales: Weir, Matthew R., Mayo, Martha R., Garza, Dahlia, Arthur, Susan A., Berman, Lance, Bushinsky, David, Wilson, Daniel J., Epstein, Murray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377986/
https://www.ncbi.nlm.nih.gov/pubmed/28129247
http://dx.doi.org/10.1097/HJH.0000000000001278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377986/
https://www.ncbi.nlm.nih.gov/pubmed/28129247
http://dx.doi.org/10.1097/HJH.0000000000001278

Ejemplares similares